Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report

Abstract

Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-kappa MM treated with intrapleural bortezomib with systemic bortezomib-based therapy.

Although we observed good local response, the patient succumbed due to systemic myeloma progression.

Keywords

• Myelomatous pleural effusion (MPE)
• multiple myeloma (MM)
• intrapleural bortezomib
• antimyeloma drugs